Vet Pathol Email Content Delivery
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
This Article
Right arrow Abstract Freely available
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Citing Articles
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Restucci, B.
Right arrow Articles by Maiolino, P.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Restucci, B.
Right arrow Articles by Maiolino, P.
Vet Pathol 37:297-301 (2000)
© 2000 American College of Veterinary Pathologists

Evaluation of Angiogenesis in Canine Mammary Tumors by Quantitative Platelet Endothelial Cell Adhesion Molecule Immunohistochemistry

B. Restucci, G. De Vico and P. Maiolino

Dipartimento di Patologia e Sanità Animale, Settore Anatomia Patologica, Facoltà di Medicina Veterinaria, Università di Napoli, Italia (BR, PM); and Istituto di Patologia Generale e Anatomia Patologica, Facoltà di Medicina Veterinaria, Università di Messina, Italia (GDV)


   Abstract
Top
 Abstract
Material and Methods
 Results
 Discussion
 References
 
Angiogenesis was evaluated by immunohistochemistry for platelet endothelial cell adhesion molecule (CD31) in a series of benign and malignant canine mammary neoplasms. Computer image analysis was used to measure the intratumoral microvessel density (number of microvessels per square millimeter) and the area and perimeter of immunolabeled vascular structures. A higher intratumoral microvessel density and lower values for area and perimeter were found in malignant neoplasms compared with benign tumors and among the malignant tumors, in less differentiated phenotypes and in more anaplastic histological types (solid and squamous carcinomas), most of which had metastasized. These findings are consistent with an increase in angiogenesis in multistage neoplasia. Therefore, in more anaplastic malignant neoplasms, numerous but small and often malformed new vessels can be identified. The correlation of angiogenesis data with differentiation grade and histological type of mammary neoplasms is consistent with the findings in human medicine and demonstrates that angiogenesis can also have a prognostic value in veterinary medicine.

Key words: Angiogenesis; canine mammary neoplasms; image analysis; immunohistochemistry.

Angiogenesis is a complex multistep process characterized by the formation of new capillaries from the preexisting vascular network. In neoplasms, it is essential for tumor growth and metastasis.1,8,12

Endothelial cells proliferate 30–40-fold faster in tumor blood vessels than in the vasculature of normal tissues.17 Furthermore, several studies have demonstrated a significant correlation between marked angiogenesis, evidenced by a high microvessel density (number of microvessels per square millimeter), metastasis, and poor prognosis in several human tumor types, including breast,10,18,30 prostate,31 and non-small cell lung carcinomas,13 cutaneous melanomas,27 and testicular germ cell tumors.22 Therefore, the angiogenic characteristic of a neoplasm is considered a powerful prognostic tool in human medicine.26,31 On the other hand, angiogenesis and its relation to biologic behavior of neoplasms are still poorly understood in veterinary oncology.

Unfortunately, the methods for measuring angiogenesis still represent a problem. The method suggested by Weidner et al.,30 in which the microvessel density was assessed by counting the immunolabeled vessels only in the most vascularized areas of neoplasm (hot spots), has given conflicting results. Recently, new methods of tumor angiogenesis measurement using computerized image analysis, which allow us to evaluate not only the number of microvessels but also other vascular parameters, such as area and perimeter, have been proposed.2,3,11,28

Therefore, the aim of the present study was to use computerized image analysis to measure angiogenesis in a series of canine mammary tumors to assess microvessel density and, in addition, area and perimeter of each vessel, and to correlate these parameters with differentiation grade and histological type of neoplasia.


   Material and Methods
Top
 Abstract
 Material and Methods
Results
 Discussion
 References
 
Samples

Forty samples of canine mammary tumors, 10 benign and 30 malignant, were examined. Tumors were classified by World Health Organization criteria15 as listed in Table 1 and were graded as moderately to poorly differentiated (grades 1 to 3) by two independent observers. The parameters used were 1) extent of tubule formation (for tubular and papillary adenocarcinomas), 2) nuclear hyperchromatism and number of mitoses, and 3) irregularity of size, shape, and staining of nuclei.19


View this table:
[in this window]
[in a new window]
  		Table 1. WHO classification of canine mammary tumors used in this study.

 
Among the malignant tumors, two of eight tubular adenocarcinomas, three of six solid carcinomas, and two of three squamous cell carcinomas, all grade 3 (58.3%), had already metastasized to the inguinal lymph nodes at the time of diagnosis. Two of three early metastatic solid carcinomas metastasized to the lung after 2 years. Three of eight tubular adenocarcinomas, grade 2 (30%), and two of six solid carcinomas, grade 3 (16.6%), which had not metastasized at the time of diagnosis, spread to lungs, liver, and bones after 2 years.

Immunohistochemistry

All samples were fixed in 10% neutral buffered formalin and embedded in paraffin. Sections 5 µm thick were deparaffinized in xylene, dehydrated in graded alcohols, and washed in 0.01 M phosphate-buffered saline (PBS), pH 7.2–7.4. Endogenous peroxidase was blocked with 0.3% hydrogen peroxide in absolute methanol for 30 minutes. Before the immunohistochemical procedure, a proteolytic treatment with 0.4% pepsin in 0.01 m HCl was applied for 30 minutes at 37 C. The primary antibody was a monoclonal mouse anti-human platelet endothelial cell adhesion molecule (PECAM), also called CD31 (clone JC70; Dako, Denmark), a 100-kd glycoprotein that participates in the adhesion between platelets and endothelial cells.21 PECAM antigen is regarded in humans as a useful marker for endothelial cells because it is consistently expressed on all types of endothelial cells, and it is expressed only by endothelial cells, platelets, and macrophages.25 The antibody against human PECAM antigen also recognizes the canine antigen.5

The antibody was diluted 1:20 in Tris-HCl buffer containing 0.5% bovine serum albumin and 0.015 M sodium azide (Dako). The sections were incubated overnight at 4 C. The immunolabeling procedure included negative control sections incubated in PBS without primary antibody. Biotinylated anti-mouse, anti-rabbit, and anti-goat immunoglobulins (labeled streptavidin biotin [LSAB] Kit; Dako) diluted in PBS were used as secondary antibodies; they were applied for 30 minutes. After washing in PBS, the sections were incubated in streptavidin conjugated to horseradish peroxidase in Tris-HCl buffer containing sodium azide 0.015% (LSAB kit; Dako) for 30 minutes. To demonstrate the immunolabeling, 3,3-diaminobenzidine tetrahydrochloride was used as chromogen, and hematoxylin was sued as counterstain.

Image analysis

Intratumoural microvessel density was assessed randomly by choosing immunolabeled vessels on a 400x field (40x objective and 10x ocular) using an automated (Image Pro-Plus 1) image analysis system (Sistema MONO, Immagini e Computer, Milan, Italy). Twenty fields per tumor were examined.

Images were captured using a microscope (Nikon Eclipse E-400, Tokyo, Japan) coupled to a video camera (JVC TK-C1380E, Japan), stored in the digital memory, and shown on the monitor. Manual outlining of intratumoral microvessels was performed; areas, perimeters (expressed in millimeters), and number of vessels per square millimeter were then calculated based on image analysis. Every immunolabeled endothelial cell separate from adjacent microvessels, tumor cells, and other connective tissue elements was counted as a single microvessel. All the vessels in the stroma outside tumors were considered as normal controls.

Statistical analysis

The vascular parameters expressed by mean and standard deviation were correlated with histological type and differentiation grade of mammary neoplasms by analysis of variance.


   Results
Top
 Abstract
 Material and Methods
 Results
Discussion
 References
 
The microvessel number per 0.304 mm2 of image analysis was higher in malignant than in benign neoplasms (P < 0.0001). Among the malignant neoplasms, the density increased progressively, proceeding from differentiation grade 1 to 3 (P < 0.0001) and in more anaplastic histological types (solid and squamous carcinomas; P < 0.0001), as shown in Table 2 and 3.


View this table:
[in this window]
[in a new window]
  		Table 2. Correlation of number, area, and perimeter of vessels with differentiation grade of neoplasms.

 

View this table:
[in this window]
[in a new window]
  		Table 3. Correlation of number, area, and perimeter of vessels with histological type of neoplasms.

 
In benign neoplasms and grade 1 papillary and tubular adenocarcinomas, intratumoral microvessels were wide and regular in shape, with erythrocytes evident in the lumens (Fig. 1). In grade 2 and 3 neoplasms and in more anaplastic histological types, the microvessels were small and irregular in shape often without a distinct lumen (Fig. 2). In addition, in two solid carcinomas that metastasized early, mostly isolated endothelial cells were present.



View larger version (162K):
[in this window]
[in a new window]
  		Fig. 1. Canine tubular adenocarcinoma, grade 1. Immunostaining for PECAM shows wide vessels, regular in shape, containing erythrocytes. Streptavidin–biotin–peroxidase. Bar = 15 µm.

 


View larger version (163K):
[in this window]
[in a new window]
  		Fig. 2. Canine tubular adenocarcinoma, grade 2. Immunostaining for PECAM shows small vessels, irregular in shape and without lumen. Some isolated positive endothelial cells are evident (arrows). Streptavidin–biotin–peroxidase. Bar = 25 µm.

 
Areas and perimeter were smaller in malignant than in benign neoplasms (area P = 0.0002 and perimeter P = 0.0001). Among the malignant neoplasms, these parameters were smaller in grade 3 versus grade 1 tumors (area P = 0.0006 and perimeter P = 0.0004; not shown). Based on histological type, areas and perimeter were smaller in solid and squamous carcinomas than in papillary and tubular adenocarcinomas, whereas mixed tumors showed intermediate values (area P = 0.005 and perimeter P = 0.004; not statistically significant), as detailed in Tables 2 and 3.


   Discussion
Top
 Abstract
 Material and Methods
 Results
 Discussion
References
 
In normal tissues, new vessel formation is regulated by many stimulatory and inhibitory factors, which function in a delicate balance.8 Any change in tissue homeostasis, either physiological or pathological, can perturb the balance and result in acquisition of an angiogenic phenotype.9,16 On the other hand, in experimental and clinical studies, a tumor generally acquires characteristics of malignancy, such as rapid growth and metastatic capability, when angiogenesis increases.7,14,30,31

In this study, in a series of canine mammary tumors, as in comparable human studies, a higher microvessel density was detected in malignant neoplasms. In addition, in poorly differentiated and metastasizing carcinomas, increased angiogenesis was demonstrated.

One hypothesis for increased angiogenesis is that, as mutations accumulate in tumors, some clones of neoplastic cells switch to an angiogenic phenotype.16 The molecular basis of the angiogenic switch is not entirely clear but may involve an increase in angiogenesis stimulators, a decrease in angiogenesis inhibitors, or a combination of the two.6 More precisely, the malignant transformation could be linked to the loss of suppressor genes that encode angiogenesis inhibitors such as angiostatin or thrombospondin-1,24 to the activation of oncogenes encoding angiogenesis inducers such as vascular endothelial growth factor or fibroblast growth factor,4,23 or both.

The decrease in size of the intratumoral vessels detected in malignant neoplasms and, among these, in less differentiated tumors, can be a consequence of the increased angiogenesis, which can give rise to numerous but small and often abnormal new vessels. For example, in our study, two less differentiated and early metastasizing carcinomas showed many isolated endothelial cells, probably reflecting a very high angiogenic and metastatic potential. Some authors have demonstrated that endothelial cell proliferation index and intratumoral microvessel density were both correlated with poor prognosis and metastasis in many neoplasms, but one was independent from the other.10,29 In this regard, it is worthwhile to remember that endothelial cells can foster metastasis not only by inducing new vessel formation, but also by producing collagenase and other degradative enzymes, thus making it easier for neoplastic cells to escape into the neovasculature.20 In addition, endothelial cells can also stimulate the growth of tumor cells.32

Therefore, with an increase in vessels, there are more endothelial cells and a greater risk for tumor growth and dissemination. A key step in this process is the angiogenic switch of the neoplastic cells. This suggests that in tumor therapy, inhibition of angiogenesis by administration of inhibitors could prevent the growth of neoplastic cells and metastasis.6,16 In this regard, canine mammary tumors may be useful models for therapeutic trials.

In conclusion, in veterinary medicine, the microvessel density as an expression of angiogensis may be used as a sensitive parameter correlated with malignancy. In addition, the evaluation of microvessel size may give useful adjunct information about the angiogenic potential of a neoplasm.


   Acknowledgments
 
This work was supported by grants from Ministero della Ricerca Scientifica e Tecnologica 1997. We thank Mr. R. Ilsami for his technical assistance.


   References
Top
 Abstract
 Material and Methods
 Results
 Discussion
 References
 

  1. Blood CH, Zetter BR: Tumor interaction with the vasculature: angiogenesis and tumor metastasis. Biochim Biophys Acta 1032:89-118, 1990[Medline]
  2. Charpin C, Devictor B, Bergeret D: CD31 quantitative immunocytochemical assays in breast carcinomas. Correlation with current prognostic factors. Am J Clin Pathol 103:443-448, 1995[Medline]
  3. Charpin C, Garcia S, Bouvier C: CD31/PECAM automated and quantitative immunocytochemical assay in breast carcinomas. Correlation with patient follow-up. Am J Clin Pathol 107:534-541, 1997[Medline]
  4. Ferrara N: Vascular endothelial growth factor. Trends Cardiovasc Med 3:244-250, 1993[CrossRef]
  5. Ferrer L, Fondevila D, Rabanal RM: Immunohistochemical detection of CD31 antigen in normal and neoplastic canine endothelial cells. J Comp Pathol 112:319-326, 1995[CrossRef][Medline]
  6. Fidler IJ, Ellis LM: The implications of angiogenesis for biology and therapy of cancer metastasis. Cell 79:185-188, 1994[CrossRef][Medline]
  7. Folkman J, Watson K, Ingber D: Induction of angiogenesis during the transition from hyperplasia to neoplasia. Nature 339:58-61, 1989[CrossRef][Medline]
  8. Folkman J: What is the evidence that tumors are angiogenesis-dependent? J Natl Cancer Inst 82:4-6, 1990[Free Full Text]
  9. Folkman J, Shing Y: Angiogenesis. J Biol Chem 267:10931-10934, 1992[Free Full Text]
  10. Fox SB, Gatter KC, Bicknell R: Relationship of endothelial cell proliferation to tumor vascularity in human breast cancer. Cancer Res 53:4161-4163, 1993[Abstract/Free Full Text]
  11. Fox SB, Russel DL, Weekes MP: Quantitation and prognostic value of angiogenesis: comparison of microvessel density, Chalkley count, and computer image analysis. J Pathol 177:275-283, 1995[CrossRef][Medline]
  12. Fox SB, Gatter KC, Harris AL: Tumour angiogenesis. J Pathol 179:232-237, 1996[CrossRef][Medline]
  13. Giatromanolaki A, Koukourakis M, O'Byrne K: Prognostic value of angiogenesis in operable non-small cell lung cancer. J Pathol 179:80-88, 1996[CrossRef][Medline]
  14. Gimbrone MAJ, Leapman SB, Cotran RS: Tumor dormancy in vivo by prevention of neovascularization. J Exp Med 136:261-276, 1972[Abstract]
  15. Hampe JF, Misdorp W: Tumours and dysplasia of the mammary gland. Bull World Health Organ 50:111-113, 1974[Medline]
  16. Hanahan D, Folkman J: Patterns and emerging mechanism of the angiogenis switch during tumorigenesis. Cell 86:353-364, 1996[CrossRef][Medline]
  17. Hobson B, Denekamp J: Endothelial cell proliferation in tumours and normal tissues: continuous labelling studies. Br J Canc 49:405-413, 1984[Medline]
  18. Jacquemier JD, Penault-Llorca FM, Bertucci F: Angiogenesis as a prognostic marker in breast carcinoma and conventional adjuvant chemotherapy: a multiparametric and immunohistochemical analysis. J Pathol 184:130-135, 1998[CrossRef][Medline]
  19. Misdorp W: Histologic classification and further characterization of tumours in domestic animals. Adv Vet Sci Comp Med 20:191-221, 1976[Medline]
  20. Moscatelli D, Gross J, Rifkin D: Ángiogenic factors stimulate plasminogen activator and collagenase production by capillary endothelial cells. J Cell Biol 91:120a, 1981
  21. Newman PJ, Berndt MC, Gorski J: PECAM-1 (CD31) cloning and relation to adhesion molecules of the immunoglobulin gene superfamily. Science 247:1219-1222, 1990[Abstract/Free Full Text]
  22. Olivarez D, Ulbright T, DeRiese W: Neovascularization in clinical stage A testicular germ tumor: prediction of metastatic disease. Cancer 78:226-231, 1996[CrossRef][Medline]
  23. Olofsson B, Pajusola K, Kaipainen A: Vascular endothelial growth factor B, a novel growth factor for endothelial cells. Proc Natl Acad Sci USA 93:2576-2581, 1996[Abstract/Free Full Text]
  24. O'Reilly MS, Holmgren L, Shing Y: Angiostatin: a novel angiogenesis inhibitor mediates the suppression of metastases by a Lewis lung carcinoma. Cell 79:315-328, 1994[CrossRef][Medline]
  25. Parums DV, Cordell JL, Micklem F: JC70: a new monoclonal antibody that detects vascular endothelium associated antigen on routinely processed tissue sections. J Clin Pathol 43:752-757, 1990[Abstract/Free Full Text]
  26. Pazouki S, Chisholm DM, Adi MM: The association between tumour progression and vascularity in the oral mucosa. J Pathol 183:39-43, 1997[CrossRef][Medline]
  27. Srivastava A, Laidler P, Davies R: The prognostic significance of tumor vascularity in intermediate-thickness (0.76–4.0 mm thick) skin melanoma. Am J Pathol 133:419-423, 1988[Abstract]
  28. Van Der Laak JAWM, Westphal JR, Schalkwijk M: An improved procedure to quantify tumour vascularity using true color image analysis. Comparison with the manual hot-spot procedure in a human melanoma xenograft model. J Pathol 184:136-143, 1998[CrossRef][Medline]
  29. Vartanian RK, Weidner N: Correlation of intratumoral endothelial cell proliferation with microvessel density (tumor angiogenesis) and tumor cell proliferation in breast carcinoma. Am J Pathol 144:1188-1194, 1994[Abstract]
  30. Weidner N, Semple JP, Welch WR: Tumour angiogenesis and metastasis—correlation in invasive breast carcinoma. N Engl J Med 324:1-8, 1991[Abstract]
  31. Weidner N, Carroll JF, Blumenfeld W: Tumor angiogenesis correlates with metastasis in invasive prostate carcinoma. Am J Pathol 143:401-409, 1993[Abstract]
  32. Weidner N: Tumoural vascularity as a prognostic factor in cancer patients: the evidence continues to grow. J Pathol 184:119-122, 1998[CrossRef][Medline]
Request reprints from B. Restucci, Dipartimento di Patologia e Sanità Animale, Settore Anatomia Patologica, Facoltà di Medicina Veterinaria, Via Veterinaria 1, 80137, Napoli (Italy).





This Article
Right arrow Abstract Freely available
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Citing Articles
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Restucci, B.
Right arrow Articles by Maiolino, P.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Restucci, B.
Right arrow Articles by Maiolino, P.

HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS